Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Jefferson Research
Provider: ValuEngine, Inc.
Provider: Wright Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

GenMark Diagnostics Inc Lowers FY 2013 Revenue Guidance

Tuesday, 12 Nov 2013 04:02pm EST 

GenMark Diagnostics Inc announced that for fiscal 2013, it expects adjusting revenue guidance to approximately $27 million. According to I/B/E/S Estimates, analysts are expecting the Company to report revenues of $29 million for fiscal 2013. 

Company Quote

0.01 +0.11%
17 Apr 2014